| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Core Binding Factor Alpha 1 Subunit | 26 | 2017 | 30 | 3.960 |
Why?
|
| Bone Neoplasms | 9 | 2021 | 117 | 2.660 |
Why?
|
| Breast Neoplasms | 9 | 2021 | 375 | 2.240 |
Why?
|
| Transcription Factors | 19 | 2015 | 149 | 1.310 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2021 | 111 | 1.070 |
Why?
|
| Cell Nucleus | 21 | 2011 | 69 | 0.880 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 56 | 0.840 |
Why?
|
| Osteoblasts | 13 | 2011 | 52 | 0.820 |
Why?
|
| Animals | 35 | 2021 | 3238 | 0.780 |
Why?
|
| Mice | 25 | 2021 | 1224 | 0.740 |
Why?
|
| Cell Proliferation | 11 | 2021 | 164 | 0.740 |
Why?
|
| Cell Movement | 4 | 2017 | 77 | 0.710 |
Why?
|
| Glutamine | 1 | 2021 | 6 | 0.690 |
Why?
|
| Protein Kinase C | 1 | 2021 | 47 | 0.680 |
Why?
|
| MAP Kinase Signaling System | 4 | 2016 | 35 | 0.670 |
Why?
|
| Cell Line, Tumor | 11 | 2021 | 242 | 0.670 |
Why?
|
| Transcription, Genetic | 14 | 2009 | 96 | 0.640 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2014 | 26 | 0.580 |
Why?
|
| Signal Transduction | 10 | 2017 | 393 | 0.550 |
Why?
|
| Autophagy | 1 | 2017 | 28 | 0.520 |
Why?
|
| Gene Expression Regulation | 10 | 2011 | 229 | 0.500 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 21 | 0.490 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 11 | 0.480 |
Why?
|
| DNA-Binding Proteins | 10 | 2010 | 224 | 0.480 |
Why?
|
| Osteolysis | 3 | 2014 | 111 | 0.470 |
Why?
|
| Transcriptional Activation | 4 | 2010 | 27 | 0.450 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2014 | 3 | 0.450 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 43 | 0.440 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2014 | 2 | 0.430 |
Why?
|
| Nuclear Proteins | 5 | 2015 | 72 | 0.430 |
Why?
|
| Multiprotein Complexes | 1 | 2014 | 3 | 0.430 |
Why?
|
| Mammary Glands, Human | 2 | 2014 | 7 | 0.430 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 13 | 0.430 |
Why?
|
| RNA Interference | 5 | 2017 | 36 | 0.400 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2009 | 31 | 0.400 |
Why?
|
| Growth Differentiation Factor 10 | 1 | 2012 | 1 | 0.380 |
Why?
|
| Humans | 36 | 2021 | 22592 | 0.380 |
Why?
|
| Gene Silencing | 1 | 2012 | 23 | 0.380 |
Why?
|
| Cell Differentiation | 7 | 2011 | 125 | 0.380 |
Why?
|
| Nuclear Matrix | 5 | 2007 | 5 | 0.370 |
Why?
|
| Neoplasm Proteins | 4 | 2005 | 50 | 0.360 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 4 | 0.340 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 6 | 0.340 |
Why?
|
| Tumor Microenvironment | 3 | 2021 | 17 | 0.340 |
Why?
|
| Transforming Growth Factor beta | 6 | 2008 | 80 | 0.330 |
Why?
|
| Bone Resorption | 1 | 2010 | 75 | 0.330 |
Why?
|
| Models, Biological | 7 | 2021 | 300 | 0.320 |
Why?
|
| Mice, SCID | 4 | 2017 | 40 | 0.320 |
Why?
|
| Proteins | 6 | 2004 | 52 | 0.310 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 31 | 0.310 |
Why?
|
| Cell Survival | 3 | 2021 | 98 | 0.300 |
Why?
|
| Hedgehog Proteins | 1 | 2008 | 6 | 0.300 |
Why?
|
| RNA, Small Interfering | 5 | 2014 | 76 | 0.280 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 529 | 0.270 |
Why?
|
| Female | 10 | 2021 | 12734 | 0.270 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2014 | 6 | 0.270 |
Why?
|
| Protein Transport | 6 | 2017 | 29 | 0.260 |
Why?
|
| Cells, Cultured | 8 | 2012 | 467 | 0.250 |
Why?
|
| Gene Expression | 7 | 2009 | 174 | 0.250 |
Why?
|
| Neoplasm Invasiveness | 3 | 2014 | 84 | 0.240 |
Why?
|
| Bone Morphogenetic Proteins | 4 | 2008 | 63 | 0.240 |
Why?
|
| MCF-7 Cells | 2 | 2017 | 15 | 0.240 |
Why?
|
| Phosphorylation | 3 | 2014 | 131 | 0.240 |
Why?
|
| Bone and Bones | 4 | 2010 | 108 | 0.240 |
Why?
|
| Neoplasm Metastasis | 4 | 2010 | 99 | 0.230 |
Why?
|
| DNA | 5 | 2004 | 95 | 0.220 |
Why?
|
| Down-Regulation | 2 | 2021 | 88 | 0.220 |
Why?
|
| Promoter Regions, Genetic | 6 | 2012 | 84 | 0.220 |
Why?
|
| Epigenesis, Genetic | 3 | 2009 | 61 | 0.220 |
Why?
|
| Neoplasms | 4 | 2008 | 216 | 0.210 |
Why?
|
| DNA Helicases | 2 | 2015 | 3 | 0.210 |
Why?
|
| Osteogenesis | 4 | 2009 | 100 | 0.200 |
Why?
|
| Epithelial Cells | 2 | 2014 | 70 | 0.190 |
Why?
|
| Prostatic Neoplasms | 2 | 2014 | 91 | 0.170 |
Why?
|
| Biosynthetic Pathways | 1 | 2021 | 1 | 0.170 |
Why?
|
| Glycolysis | 1 | 2021 | 11 | 0.170 |
Why?
|
| Microscopy, Fluorescence | 3 | 2004 | 68 | 0.160 |
Why?
|
| Cell Cycle | 4 | 2015 | 33 | 0.160 |
Why?
|
| Cell Lineage | 3 | 2009 | 25 | 0.160 |
Why?
|
| Cell Line | 4 | 2014 | 250 | 0.150 |
Why?
|
| Transfection | 2 | 2017 | 119 | 0.150 |
Why?
|
| Smad Proteins | 2 | 2008 | 3 | 0.140 |
Why?
|
| Gene Knockdown Techniques | 2 | 2016 | 41 | 0.140 |
Why?
|
| HeLa Cells | 6 | 2008 | 36 | 0.140 |
Why?
|
| Autophagosomes | 1 | 2017 | 1 | 0.140 |
Why?
|
| Tubulin | 1 | 2017 | 15 | 0.130 |
Why?
|
| Acetylation | 1 | 2017 | 12 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 14 | 0.130 |
Why?
|
| Chloroquine | 1 | 2017 | 7 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2017 | 30 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 24 | 0.130 |
Why?
|
| Microtubules | 1 | 2017 | 26 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 5 | 2008 | 42 | 0.130 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2008 | 19 | 0.130 |
Why?
|
| Bone Development | 3 | 2008 | 30 | 0.120 |
Why?
|
| Benzamides | 1 | 2016 | 12 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2016 | 29 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2011 | 280 | 0.120 |
Why?
|
| Metformin | 1 | 2016 | 15 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 5 | 2011 | 60 | 0.120 |
Why?
|
| Mitosis | 4 | 2009 | 7 | 0.120 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2015 | 16 | 0.120 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 196 | 0.120 |
Why?
|
| Core Binding Factor alpha Subunits | 5 | 2007 | 5 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 67 | 0.120 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2010 | 5 | 0.110 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2014 | 2 | 0.110 |
Why?
|
| Receptor Cross-Talk | 1 | 2014 | 7 | 0.110 |
Why?
|
| Skull | 2 | 2012 | 16 | 0.110 |
Why?
|
| RNA | 2 | 2005 | 31 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 33 | 0.110 |
Why?
|
| Epidermal Growth Factor | 1 | 2014 | 26 | 0.110 |
Why?
|
| ErbB Receptors | 1 | 2014 | 53 | 0.110 |
Why?
|
| Repressor Proteins | 2 | 2012 | 33 | 0.110 |
Why?
|
| Mesoderm | 2 | 2012 | 18 | 0.110 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2005 | 34 | 0.110 |
Why?
|
| Cell Division | 2 | 2005 | 80 | 0.110 |
Why?
|
| Mice, Transgenic | 2 | 2012 | 175 | 0.110 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 4 | 0.110 |
Why?
|
| Chromones | 1 | 2014 | 9 | 0.110 |
Why?
|
| Morpholines | 1 | 2014 | 14 | 0.110 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Integrins | 1 | 2014 | 9 | 0.110 |
Why?
|
| Epitopes | 2 | 2004 | 39 | 0.110 |
Why?
|
| Antigens, Neoplasm | 1 | 2014 | 40 | 0.110 |
Why?
|
| Parathyroid Hormone-Related Protein | 2 | 2014 | 3 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2014 | 144 | 0.100 |
Why?
|
| Mutation | 3 | 2009 | 327 | 0.100 |
Why?
|
| Apoptosis | 1 | 2014 | 195 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2012 | 2 | 0.100 |
Why?
|
| Cell Growth Processes | 1 | 2012 | 6 | 0.100 |
Why?
|
| Amino Acids | 2 | 2008 | 18 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 16 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 22 | 0.090 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2015 | 5 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2011 | 37 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 124 | 0.090 |
Why?
|
| Stem Cells | 2 | 2008 | 34 | 0.090 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2010 | 1 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2010 | 23 | 0.090 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2010 | 21 | 0.090 |
Why?
|
| Extremities | 1 | 2010 | 24 | 0.090 |
Why?
|
| Cell Polarity | 1 | 2009 | 3 | 0.080 |
Why?
|
| Chromatin | 3 | 2004 | 14 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2009 | 30 | 0.080 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2009 | 1 | 0.080 |
Why?
|
| Sterols | 1 | 2009 | 3 | 0.080 |
Why?
|
| Cell Compartmentation | 2 | 2007 | 8 | 0.080 |
Why?
|
| Radiography | 1 | 2010 | 522 | 0.080 |
Why?
|
| Cleidocranial Dysplasia | 1 | 2008 | 1 | 0.080 |
Why?
|
| Mice, Mutant Strains | 2 | 2005 | 19 | 0.070 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2008 | 1 | 0.070 |
Why?
|
| Genes, bcl-1 | 1 | 2008 | 2 | 0.070 |
Why?
|
| Tissue Distribution | 1 | 2008 | 32 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 20 | 0.070 |
Why?
|
| Osteoclasts | 1 | 2008 | 20 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 147 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 130 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2008 | 23 | 0.070 |
Why?
|
| Disease Progression | 1 | 2010 | 517 | 0.070 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2005 | 33 | 0.070 |
Why?
|
| Cellular Senescence | 1 | 2007 | 15 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 2 | 2007 | 8 | 0.070 |
Why?
|
| Genes, rRNA | 1 | 2007 | 1 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2005 | 113 | 0.070 |
Why?
|
| Vitamin D | 2 | 2007 | 27 | 0.070 |
Why?
|
| Mice, Knockout | 4 | 2008 | 277 | 0.070 |
Why?
|
| 3T3 Cells | 1 | 2005 | 9 | 0.060 |
Why?
|
| Adenoviridae | 1 | 2005 | 15 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2005 | 23 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2005 | 30 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2005 | 7 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 22 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2005 | 23 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 130 | 0.060 |
Why?
|
| Osteocytes | 1 | 2005 | 18 | 0.060 |
Why?
|
| Transcription Factor AP-2 | 4 | 2005 | 4 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2005 | 23 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 1 | 2005 | 13 | 0.060 |
Why?
|
| Cartilage | 1 | 2005 | 70 | 0.060 |
Why?
|
| Uridine Triphosphate | 1 | 2004 | 1 | 0.050 |
Why?
|
| Deoxyribonuclease I | 1 | 2004 | 2 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2004 | 9 | 0.050 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 12 | 0.050 |
Why?
|
| Staining and Labeling | 1 | 2004 | 14 | 0.050 |
Why?
|
| Protein Binding | 3 | 2011 | 114 | 0.050 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2008 | 55 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2008 | 109 | 0.050 |
Why?
|
| Phenotype | 3 | 2008 | 255 | 0.050 |
Why?
|
| Male | 3 | 2014 | 12260 | 0.040 |
Why?
|
| Rats | 3 | 2005 | 625 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2008 | 148 | 0.040 |
Why?
|
| Molecular Sequence Data | 2 | 2008 | 186 | 0.040 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 13 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2007 | 10 | 0.030 |
Why?
|
| Base Sequence | 2 | 2007 | 100 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 9 | 0.030 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 8 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2008 | 354 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 11 | 0.030 |
Why?
|
| Biomarkers | 2 | 2008 | 455 | 0.030 |
Why?
|
| Calcification, Physiologic | 2 | 2005 | 18 | 0.030 |
Why?
|
| Cell Fractionation | 2 | 2004 | 5 | 0.030 |
Why?
|
| Receptors, Androgen | 1 | 2014 | 6 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 10 | 0.020 |
Why?
|
| Oligopeptides | 1 | 2011 | 21 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 110 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2010 | 2 | 0.020 |
Why?
|
| SMARCB1 Protein | 1 | 2010 | 2 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2010 | 8 | 0.020 |
Why?
|
| Flavonoids | 1 | 2010 | 15 | 0.020 |
Why?
|
| Hematopoiesis | 1 | 2010 | 10 | 0.020 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2010 | 19 | 0.020 |
Why?
|
| Histones | 1 | 2010 | 28 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 130 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2009 | 22 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 50 | 0.020 |
Why?
|
| Mitochondria | 1 | 2009 | 54 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 198 | 0.020 |
Why?
|
| Clavicle | 1 | 2008 | 11 | 0.020 |
Why?
|
| Growth Plate | 1 | 2008 | 13 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 34 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2008 | 19 | 0.020 |
Why?
|
| Biological Clocks | 1 | 2008 | 11 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2007 | 9 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2007 | 8 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2007 | 22 | 0.020 |
Why?
|
| Chromatids | 1 | 2007 | 1 | 0.020 |
Why?
|
| RNA Polymerase I | 1 | 2007 | 1 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2007 | 1 | 0.020 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2007 | 1 | 0.020 |
Why?
|
| Metaphase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 6 | 0.020 |
Why?
|
| Interphase | 1 | 2007 | 5 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2007 | 4 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 578 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 20 | 0.020 |
Why?
|
| Protein Sorting Signals | 1 | 2006 | 2 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 30 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2007 | 58 | 0.020 |
Why?
|
| Smad5 Protein | 1 | 2005 | 1 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 11 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 40 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 25 | 0.010 |
Why?
|
| G1 Phase | 1 | 2005 | 16 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 38 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2005 | 17 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2005 | 17 | 0.010 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2005 | 19 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2005 | 24 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 50 | 0.010 |
Why?
|
| Collagenases | 1 | 2005 | 14 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 67 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2005 | 35 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 175 | 0.010 |
Why?
|
| Cell Physiological Phenomena | 1 | 2004 | 5 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 139 | 0.010 |
Why?
|
| Homeostasis | 1 | 2004 | 65 | 0.010 |
Why?
|
| DNA Footprinting | 1 | 2004 | 1 | 0.010 |
Why?
|
| Nucleosomes | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 10 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 19 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2004 | 22 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 54 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 33 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 43 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 150 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2004 | 40 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 51 | 0.010 |
Why?
|
| Genomics | 1 | 2004 | 50 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 66 | 0.010 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2003 | 3 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 333 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 163 | 0.010 |
Why?
|
| Osteocalcin | 1 | 2003 | 25 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 1247 | 0.010 |
Why?
|